RemSleep Holdings Inc., the developer of the FDA-cleared Deltawave™ CPAP mask system, has announced the finalization of contracts with independent sales representatives covering the entire United States. The company reported that fulfillment inventory for the Deltawave™ system has arrived and is ready to meet the needs of durable medical equipment providers and customers. RemSleep is also developing instructional materials, including a video and a brochure, to support the sales team. The company is currently evaluating an enterprise resource planning system to manage inventory, accounting, customer relations, and business analytics as part of its ongoing efforts to streamline operations and support product launch activities.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RemSleep Holdings Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1080557) on October 01, 2025, and is solely responsible for the information contained therein.
Comments